UBE2L3
UBE2L3 (ubiquitin conjugating enzyme E2 L3, also known as UBCH7) is an E2 ubiquitin-conjugating enzyme that accepts ubiquitin from the E1 complex and passes it on to substrate proteins. It works specifically with HECT-type and RBR family E3 ligases. Browse Assay Genie's current range of UBE2L3 research reagents below, or read on for the biology behind the target.
UBE2L3 is an E2 enzyme in the ubiquitination cascade. It accepts ubiquitin from the E1 complex and catalyses its covalent attachment to other proteins. Its partnerships are selective: it acts with HECT-type and RBR family E3 ubiquitin-protein ligases, but does not function with most RING-containing E3s because it lacks intrinsic E3-independent reactivity with lysine. It is active with RBR enzymes such as PRKN, RNF31 and ARIH1, which behave like RING-HECT hybrids. It also mediates ubiquitination by the CUL9-RBX1 complex, and in vitro it catalyses 'Lys-11'-linked polyubiquitination.
Functionally, UBE2L3 is involved in the selective degradation of short-lived and abnormal proteins. It is down-regulated during S-phase and is involved in progression through the cell cycle. It also regulates the transcriptional activity of nuclear hormone receptors and may play a role in myelopoiesis. In vitro, the enzyme participates in the ubiquitination of p53, c-Fos and the NF-kB precursor p105. The protein is found in the nucleus and cytoplasm.
The UBE2L3 gene belongs to the HGNC group of ubiquitin conjugating enzymes E2 and encodes a member of the ubiquitin-conjugating enzyme family. Several alternatively spliced transcript variants have been reported. The previous name was ubiquitin-conjugating enzyme E2L 3, and UBCH7 remains a widely used alias. The mouse ortholog is Ube2l3.
UBE2L3 is a model E2 for studying how ubiquitin is transferred and how abnormal or short-lived proteins are targeted for degradation.
Its activity with RBR E3s such as PRKN, RNF31 and ARIH1 makes it central to studies of RING-HECT hybrid ligase function.
UBE2L3 is down-regulated during S-phase and is involved in cell cycle progression, linking ubiquitin conjugation to proliferation control.
UBE2L3 regulates nuclear hormone receptor transcriptional activity, and it takes part in ubiquitination of p53, c-Fos and p105 in vitro.
UBE2L3 is an E2 enzyme that accepts ubiquitin from the E1 complex and catalyses its attachment to other proteins. It acts with HECT-type and RBR family E3 ligases, and is involved in degrading short-lived and abnormal proteins and in cell cycle progression.
Yes. UBCH7 is an alias for UBE2L3. The HGNC full name is ubiquitin conjugating enzyme E2 L3, and the previous name was ubiquitin-conjugating enzyme E2L 3. Several alternatively spliced transcript variants have been described for the gene.
UBE2L3 works with HECT-type and RBR family E3s, including PRKN, RNF31 and ARIH1, and mediates ubiquitination by the CUL9-RBX1 complex. It does not function with most RING-containing E3s. The mouse ortholog is Ube2l3; check the datasheet of any product for its validated reactivity.
Other ubiquitin-conjugating E2 enzymes and ubiquitin ligases involved in protein ubiquitination and degradation.
Gene and protein annotations from HGNC, NCBI Gene and UniProt P68036; product specifications from Assay Genie datasheets.